Analyst firms · Mizuho · SBRA

Mizuho SBRA price target and rating history

Sabra Health Care REIT Inc. (SBRA) · Real Estate

Mizuho rates Sabra Health Care REIT Inc. (SBRA) Neutral with a $20 price target, as of its latest action on Dec 5, 2024. It has published 3 rating actions on SBRA since July 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a SBRA price target in the last 12 months, the median target is $21.

Current rating
Neutral
Price target
$20
Median target, all firms
$21
Actions on SBRA
3

Mizuho price target on SBRA

$20$18$1520222023202420252026
Mizuho price target on SBRA, each point a stated target, July 2021 to December 2024.

Every Mizuho rating on SBRA

How other firms rate SBRA

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
HuntingtonOutperform$23Sep 10, 2026
Raymond JamesMkt PerformAug 6, 2026
Truist SecuritiesHoldJul 8, 2026
BarclaysOverweight$21Jul 7, 2026
CitigroupNeutral$19Jun 23, 2026

Questions about Mizuho and SBRA

What is Mizuho's price target for SBRA?
Mizuho's latest stated price target for Sabra Health Care REIT Inc. (SBRA) is $20, from its action on Dec 5, 2024.
What is Mizuho's rating on SBRA?
Mizuho rates SBRA Neutral, a neutral rating, as of Dec 5, 2024.
When did Mizuho last change its view on SBRA?
On Dec 5, 2024, Mizuho downgrades to Neutral from Outperform, price target $20.
How does Mizuho's SBRA target compare with other analysts?
Across 3 firms with a SBRA price target in the last 12 months, the median target is $21.

More SBRA rating histories

All Mizuho ratingsSBRA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.